Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine
This study is currently recruiting participants.
Verified May 2013 by Kennedy Medical Group
Sponsor:
Kennedy Medical Group
Collaborator:
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
Kennedy Medical Group
ClinicalTrials.gov Identifier:
NCT01151787
First received: June 25, 2010
Last updated: May 17, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |